Drug Database
RH

Rho(D) Immune Globulin

✓ Approved

CSL Limited · Polyclonal Antibodies · Polyclonal Antibodies

What is Rho(D) Immune Globulin?

Rho(D) Immune Globulin is a polyclonal antibodies developed by CSL Limited. It is approved for therapeutic indications via injectable (others) or intravenous (iv).

Drug Profile

CompanyCSL Limited
Drug ClassPolyclonal Antibodies, Antibody
RouteInjectable (Others), Intravenous (IV)
StatusApproved

Therapeutic Indications

Rho(D) Immune Globulin is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Congenital, familial and genetic disordersRhesus haemolytic disease of newborn✓ Approved

Related Research Articles

PubMedFrontiers in immunology2026-10-15

Myeloid cell expression of the VDR and parathyroid hormone control the host response to influenza infection in mice.

Tang Mengzhu M, Froelich Nicole E NE, Hanna Nicholas J NJ, Weaver Veronika C VC et al.

Respiratory infections caused by seasonal influenza viruses remain a major global health burden. Vitamin D receptor (VDR) signaling regulates immune responses, but the role of the VDR and its interaction with parathyroid hormone (PTH) in host resistance to H1N1 influenza infection is not understood. Global VDR knockout (KO) mice, or myeloid (M) deletion of the VDR (M-VDR KO) and the respective wildtype (WT) littermates were infected with H1N1 influenza virus. Additional experiments treated WT mice with intermittent PTH or vehicle and then infected them with a H1N1 influenza A virus. Disease severity, mortality, viral burden and clearance, lung pathology, and inflammatory cytokine responses were evaluated. H1N1 influenza infection of WT mice resulted in non-lethal disease, whereas VDR KO mice had 21% mortality, delayed viral clearance, more severe symptoms and lung pathology. The increased severity of respiratory disease was accompanied by higher type I and II interferon responses in the lungs. M-VDR KO mice had increased disease severity and delayed viral clearance compared to WT littermates. PTH-treated WT mice had increased clinical scores, influenza M gene, and cytokine responses compared to vehicle treated WT mice. The work describes a novel paradigm in which the vitamin D-PTH axis governs host resistance to influenza virus disease by controlling the amount of inflammation and the amount of virus in the lung. In addition, the data suggest that VDR expression in myeloid cells is critical for controlling the early innate immune response to influenza viruses.

PubMedThe Egyptian journal of immunology2026-10-15

Assessment of serum levels of vitamin D and tumor necrosis factor alpha in ulcerative colitis patients at Egyptian Military Hospitals: Cross-sectional observational study.

Eldahan Wedad W, Hassan Mohamed Z H MZH, Asaad Ahmed M AM, Salaheldin Mohamed M et al.

Ulcerative colitis (UC) is a chronic inflammatory disorder confined to the colonic and rectal mucosa. The disease is marked by infiltration of immune cells, leading to excessive production of inflammatory mediators. A key pro-inflammatory cytokine that plays a vital role in the pathophysiology of ulcerative colitis is tumor necrosis factor alpha (TNF-alpha). Low levels of vitamin D have been associated with several autoimmune disorders. This study aimed to assess vitamin D serum levels in UC patients as regard TNF-alpha serum levels and the Severity of UC (UCDAI). This cross-sectional observational research was carried out at Military healthcare facilities in Cairo, Egypt, over six months, from 1 July 2025 to 31 December 2025. Utilizing a convenience sample of 50 adults aged 15 to 70 years with a confirmed diagnosis of ulcerative colitis, newly diagnosed. They were divided into two groups according to disease severity (UCDAI or Mayo score): 26 patients in the mild group & 24 patients in the moderate/severe group. Demographic data were collected from patients' interviews. Colonoscopy for ulcerative colitis disease activity index (UCDAI) score, CBC, ESR, CRP, and Fecal calprotectin (FC) were investigated at Egyptian Military hospitals. Serum levels of 25-hydroxyvitamin D (using CLIA) and TNF-alpha (using ELISA) were measured at central laboratories of the armed forces and blood bank. Correlation analysis showed Serum Vitamin D had a moderate negative correlation with UCDAI (r = -0.466, p-value= 0.001), and a strong negative correlation with serum TNF-alpha (r = -0.669, p-value <0.001). Serum TNF-alpha showed a moderate positive correlation with UCDAI (r = 0.472, p-value= 0.001). Fecal calprotectin had a strong positive correlation with UCDAI (r = 0.704, p-value <0.001) and a weak positive correlation with serum TNF-alpha (r = 0.388, p-value= 0.005). In conclusion, this study demonstrates that patients with moderate to severe ulcerative colitis had pronounced mucosal and systemic inflammation, reflected by markedly elevated fecal calprotectin and TNF-alpha levels, concomitant with significantly lower vitamin D concentrations compared with those in mild disease.

PubMedZhonghua er ke za zhi = Chinese journal of pediatrics2026-10-15

[Analysis of efficacy and prognosis of allogeneic hematopoietic stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome].

Man J J, Qian X W XW, Jiang W J WJ, Wang P P et al.

Objective: To evaluate the efficacy and prognosis of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the treatment of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome in children. Methods: In this case series study, clinical characteristics, laboratory tests, transplantation protocols, post-transplant disease remission, and survival status of 9 children with IPEX syndrome who underwent allo-HSCT at the Children's Hospital of Fudan University from July 2020 to December 2025 were collected. The transplantation experiences were summarized and the efficacy and safety of allo-HSCT for IPEX children were evaluated. Results: All 9 children were males. Eight children developed symptoms within the first month of age, and 1 at 5 years of age. The initial presentations were diarrhea in 4 children, diabetes mellitus in 2 children, and rash in 3 children. FOXP3 gene variants were maternally inherited in 8 children and de novo in 1 child. A total of 11 HSCT were performed in 9 children, with an overall engraftment of 9 times. Two children who experienced primary graft failure achieved successful engraftment after second HSCT at intervals of 3 and 4 months, respectively. Donor sources included 4 haploidentical donors, 3 unrelated cord blood and 2 matched unrelated donors. All conditioning regimens were based on fludarabine and busulfan. The age at transplantation was 37.5 (12.4, 70.3) months, with a follow-up of 17.4 (9.7, 26.8) months. All 9 children survived. Eight children achieved complete donor chimerism, and 1 had mixed chimerism. The times to neutrophil and platelet engraftment were 13 (11, 18) and 9 (9, 29) d, respectively. The times for absolute CD19+and CD4+ cell counts exceed 2×108 cells/L were 165 (94, 270) and 165 (100, 183) d, respectively. Five children developed grade Ⅰ-Ⅱ acute graft versus host disease (GVHD), all presenting as skin involvement and resolved following glucocorticoid-based immunosuppressive therapy. No grade Ⅲ-Ⅳ acute GVHD or chronic GVHD occurred. Recurrent diarrhea, anemia, severe infection, eczema, and nephropathy all achieved complete remission through allo-HSCT. Among the 5 children with hypothyroidism and 2 children with diabetes mellitus, levothyroxine and insulin replacement therapy were still required, with well-controlled conditions. No new autoimmune diseases developed. Conclusions: allo-HSCT is an effective curative approach for IPEX syndrome, capable of halting disease progression, but cannot reverse pre-existing endocrine damage. No severe infections and GVHD occurred post-transplantation. Early diagnosis and early transplantation are crucial for improving outcomes.

PubMedAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026-10-15

Checkpoint-Directed Glycoengineering Reprograms the Vascular Lumen for Siglec-Mediated Immune Regulation.

Rana Md Mohosin MM, Rahim Javairia F JF, Bernstein Aaron P AP, Nouri Peyman Malek Mohammadi PMM et al.

Dysregulated immune activation at the vascular surface drives microvascular inflammation and tissue injury in many diseases, yet current therapies do not restore immune regulation at the blood-vessel interface. Terminal sialic acids engage inhibitory Siglec receptors on circulating immune cells and function as endogenous glyco-immune checkpoint ligands. Loss of sialylation on vascular endothelial cells during injury disrupts this regulatory axis and promotes vascular damage. Here, we introduce a checkpoint-directed glycoengineering strategy that installs multivalent Siglec-engaging sialic acid ligands on a macromolecular scaffold at the vascular interface to reprogram Siglec-mediated immune regulation. Covalent anchoring of Siglec-engaging conjugates to the vascular surface suppressed leukocyte-mediated cytotoxicity, inflammatory cytokine production, adhesion molecule accessibility, and complement deposition. Protection was dose-dependent and required selective sialic acid-Siglec-7/-9 engagement, as demonstrated by enzymatic desialylation, Siglec-Fc binding, and receptor blockade. In vascular allografts, this Siglec-engaging modification preserved endothelial integrity and suppressed innate and adaptive immune activation, neutrophil recruitment, dendritic-cell activation, and T-cell infiltration. In an allogeneic rat kidney transplant model, this approach attenuated microvascular inflammation, complement deposition, and tissue injury, resulting in vascular protection and demonstrating the power of glycan reprogramming. These findings establish Siglec-directed immune-glycoengineering as a mechanistically defined local checkpoint strategy that reprograms the vasculature into an active immunoregulatory interface.

PubMedNature communications2026-10-15

The ongoing invasion of the endogenous retrovirus Kuruka in natural Drosophila melanogaster populations.

Pianezza Riccardo R, Saadain Sarah S, Beaumont Matthew M, Signor Sarah S et al.

Transposable elements (TEs) are mobile DNA sequences that can proliferate within host genomes, occasionally capable of crossing species boundaries via horizontal transfer (HT). Here, we report the discovery and characterization of Kuruka, a recently invading TE in natural D. melanogaster populations. Kuruka encodes an envelope protein and belongs to the gypsy/gypsy superfamily, also called insect endogenous retroviruses. Analysis of over 1000 D. melanogaster genomes revealed that Kuruka first appeared in sub-Saharan Africa in 2010. Kuruka had spread to Asia, Europe and America in 2017-2019, and is still actively invading Europe and Oceania as of 2021. Phylogenomic analyses suggest that Kuruka entered in D. melanogaster via a recent HT from an Afrotropical Drosophila species, most likely D. erecta. This provides an example of recent TE transfer between an Afrotropical donor species and D. melanogaster. In D. erecta, Kuruka has a single genomic insertion, which is located within flamenco, a master regulator of TE activity. The presence of an active host defense (piRNAs) suggests that Kuruka is silenced in D. erecta. By capturing an invasion still in progress, our study sheds light on the processes that govern the emergence, establishment, and spread of TEs across species boundaries.

PubMedNature communications2026-10-15

Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia.

Teles Rosane M B RMB, Benabdessalem Chaouki C, Perrie Jonathan J, Wei Cenfu C et al.

Pulmonary tuberculosis (TB), caused by lung infection with Mycobacterium tuberculosis (Mtb), often manifests both alveolar pneumonia and aggregation of immune cells containing Mtb, termed granulomas, within the same lung. Here, we integrate spatial transcriptomics, single-cell RNA sequencing, high-resolution imaging, and functional assays of lung biopsies from four men with pulmonary TB to compare alveolar pneumonia with adjacent granulomas. We find that alveolar TB pneumonia is enriched for TREM2⁺ lipid-laden macrophages characterized by increased lipid metabolism gene expression, reduced T cell infiltration, attenuated antimicrobial gene expression, and abundant Mtb transcripts and antigens. By contrast, neighboring granulomas exhibit organized lymphoid architecture and robust antimicrobial programs. In vitro, Mtb lipids induce TREM2 expression, activate TREM2-DAP12 signaling, and promote lipid droplet accumulation in primary human monocyte-derived macrophages (MDM). Furthermore, TREM2+ MDMs are more susceptible to in vitro Mtb infection. When treating MDMs with 1,25-dihydroxyvitamin D₃, which induces antimicrobial macrophage programs, TREM2+ MDM numbers, lipid droplet abundance and Mtb viability are decreased. Thus, we propose a spatially localized, alveolar pneumonia-intrinsic TREM2⁺ macrophage program that potentially contributes to Mtb persistence in pulmonary TB infection in humans.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about Rho(D) Immune Globulin